Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
293.38 USD | +1.33% | +4.55% | -14.36% |
Nov. 30 | Transcript : Waters Corporation Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-30-2023 08:20 AM | CI |
Nov. 14 | North American Morning Briefing : Caution -2- | DJ |
Financials (USD)
Sales 2023 * | 2.95B | Sales 2024 * | 3.05B | Capitalization | 17.35B |
---|---|---|---|---|---|
Net income 2023 * | 615M | Net income 2024 * | 665M | EV / Sales 2023 * | 6,53x |
Net Debt 2023 * | 1.94B | Net Debt 2024 * | 1.68B | EV / Sales 2024 * | 6,24x |
P/E ratio 2023 * | 28,4x | P/E ratio 2024 * | 25,2x | Employees | 8,200 |
Yield 2023 * | - | Yield 2024 * | - | Free-Float | 36.23% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
1 day | +1.33% | ||
1 week | +4.55% | ||
Current month | +4.55% | ||
1 month | +12.55% | ||
3 months | +8.54% | ||
6 months | +14.09% | ||
Current year | -14.36% |
1 week
282.36
293.73

1 month
246.36
293.73

Current year
231.90
350.97

1 year
231.90
352.71

3 years
231.90
428.22

5 years
154.39
428.22

10 years
93.56
428.22

Managers | Title | Age | Since |
---|---|---|---|
Udit Batra
CEO | Chief Executive Officer | 52 | 2020 |
Amol Chaubal
DFI | Director of Finance/CFO | 47 | 2021 |
Caspar R. Tudor
IRC | Investor Relations Contact | - | 2020 |
Members of the board | Title | Age | Since |
---|---|---|---|
Linda Baddour
BRD | Director/Board Member | 62 | 2018 |
Director/Board Member | 69 | 2006 | |
Mark Vergnano
BRD | Director/Board Member | 65 | Nov. 22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.17% | 1,575 M€ | +11.76% | ||
3.58% | 44 M€ | 0.00% | - | |
3.42% | 2 M€ | +7.61% | - | |
3.29% | 222 M€ | +13.51% |
Date | Price | Change | Volume |
---|---|---|---|
23-12-07 | 293.38 | +1.33% | 310,434 |
23-12-06 | 289.52 | +1.60% | 354,990 |
23-12-05 | 284.95 | -1.33% | 463,764 |
23-12-04 | 288.79 | -0.02% | 413,983 |
23-12-01 | 288.85 | +2.94% | 478,726 |
Delayed Quote Nyse, December 07, 2023 at 04:00 pm EST
More quotes
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows:
- sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ;
- services (36.7%): support services, training, etc.
Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%).
Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
2024-01-23
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
Sell
Buy

Mean consensus
HOLD
Number of Analysts
19
Last Close Price
293.38USD
Average target price
272.35USD
Spread / Average Target
-7.17%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.36% | 17 347 M $ | |
-10.28% | 191 B $ | |
-17.52% | 162 B $ | |
+17.41% | 110 B $ | |
+18.93% | 80 618 M $ | |
+11.71% | 62 838 M $ | |
-10.43% | 47 899 M $ | |
-8.51% | 41 400 M $ | |
-14.01% | 37 590 M $ | |
+15.43% | 30 679 M $ |